Remote Monitoring in Diabetes Disease Management
Completed · Not applicable
Conditions studied: Type 1 Diabetes, Type 2 Diabetes
In brief
The primary objective of this study is to determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease than a standard disease management program.
Key facts
- Study ID
- NCT00675311
- Run by
- LifeScan
- People needed
- 300
- Starts
- 2008-03-01
- Expected to finish
- 2009-12-01
- Last updated by the study team
- 2009-12-18
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Between 18 and 64 years of age as of January 1, 2008
- Diagnosis of diabetes mellitus (listed ICD-9-CM diagnosis code on two or more outpatient claims, or on one or more inpatient admissions or emergency room claims in the most recent 12-month period)
- Continuously enrolled in a health plan with pharmacy and medical benefits for the most recent 12-month period or with one period of non-enrollment up to only 30 days
- Able to provide written informed consent for study participation
You may not qualify if…
- Advanced renal disease (one or more claims in the most recent 12-month period) as defined by a claim for nephropathy or creatinine greater than 2.5 mg/dl
- Selected cancers (one or more claims in the most recent 12-month period)
- HIV/AIDS (one or more claims in the most recent 12-month period)
- Heart, liver, kidney, or multiple organ transplant (one or more claims in the most recent 12-month period)
- Cirrhosis of the liver (one or more claims in the most recent 12-month period)
- Current participation in another LifeScan study or other diabetes-related clinical trials
- Medicare is primary source of insurance coverage
- Unable to understand written and spoken English
Where it is running
- Study site — Marietta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.